-
8-((1R,2S,3S)-2-(2,4-Dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl)-2',4'-dihydroxy-5-methyl-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4H-chromen-4-one
-
BD0094251776472-87-295%
-
￥1335.025mg
-
8-((1R,2S,3S)-2-(2,4-Dihydroxybenzoyl)-2',4'-dihydroxy-5-methyl-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4H-chromen-4-one
-
BD68960375629-19-598%
-
￥1210.010mg
-
(S)-3-(1H-Indol-3-yl)-N-((1-(4-methoxyphenyl)cyclohexyl)methyl)-2-(3-(4-nitrophenyl)ureido)propanamide
-
BD008417191422269-30-498%
-
￥946.05mg
-
(S)-N1-((5S,8S,11S,17S,20S,23S,26S,29S,35S,38S)-11-((1H-Imidazol-5-yl)methyl)-23-((1H-indol-3-yl)methyl)-43-amino-29-(2-amino-2-oxoethyl)-26-(3-amino-3-oxopropyl)-5-carbamoyl-43-imino-8,35-diisobutyl-17-isopropyl-20-methyl-7,10,13,16,19,22,25,28,31,34,37-undecaoxo-2-thia-6,9,12,15,18,21,24,27,30,33,36,42-dodecaazatritetracontan-38-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)pentanediamide
-
BD11853931362-50-297%
-
￥661.025mg
-
GB-6
-
BD022919082413262-74-398%
-
￥
-
(S)-3-(1H-Indol-3-yl)-2-methyl-2-(3-(4-nitrophenyl)ureido)-N-((1-(pyridin-2-yl)cyclohexyl)methyl)propanamide
-
BD01157972204066-82-097%
-
￥45781.0100mg
-
GRPR antagonist-2
-
BD0151034898%
-
￥
-
(S)-2-(4-(1H-Pyrazol-1-yl)phenyl)-1,1,1-trifluoro-3-(5-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol
-
BD6298341022152-70-098%
-
￥2421.05mg
-
Pd176252
-
BD00793167204067-01-698%
-
￥9138.0100mg
